Trials / Completed
CompletedNCT01712451
Dose-ranging Study
Dose-ranging Study of the Safety and Efficacy of Fluticasone Propionate and Salmeterol Xinafoate in Healthy Patients With Abdominal Contour Defects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Neothetics, Inc · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Dose ranging study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | salmeterol xinafoate, fluticasone propionate | LIPO-102 |
| DRUG | Placebo | Placebo |
| DRUG | salmeterol xinafoate | Salmeterol |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2012-10-23
- Last updated
- 2015-03-26
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01712451. Inclusion in this directory is not an endorsement.